GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $65,306,000 | +15.9% | 2,044,000 | +25.7% | 1.18% | +29.4% |
| Q1 2022 | $56,345,000 | +379.1% | 1,626,600 | +425.6% | 0.91% | +543.7% |
| Q3 2018 | $11,761,000 | -41.8% | 309,500 | -30.8% | 0.14% | -41.1% |
| Q2 2018 | $20,217,000 | -71.5% | 447,275 | -69.5% | 0.24% | -72.6% |
| Q1 2018 | $70,833,000 | -16.6% | 1,466,530 | -32.0% | 0.88% | -18.2% |
| Q4 2017 | $84,907,000 | +14.2% | 2,157,730 | -9.9% | 1.07% | +51.3% |
| Q3 2017 | $74,322,000 | +25.1% | 2,393,635 | +10.2% | 0.71% | +14.0% |
| Q2 2017 | $59,402,000 | +48.6% | 2,171,935 | +100.3% | 0.62% | +37.5% |
| Q1 2017 | $39,964,000 | – | 1,084,500 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |